Jonathan W. Chen
Corporate Officer/Principal at MICROPORT SCIENTIFIC CORPORATION
Profile
Presently, Jonathan W. Chen holds the position of Chief International Business Officer at MicroPort Scientific Corp. He is also on the board of Lombard Medical, Inc. and Promaxo, Inc. In the past he occupied the position of Senior Vice President-Business Development for Angiotech Pharmaceuticals, Inc. and Investment Banker at Credit Suisse First Boston Corp. He received an undergraduate degree from Stanford University.
Jonathan W. Chen active positions
Companies | Position | Start |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Corporate Officer/Principal | 31/05/2021 |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Director/Board Member | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Chairman | 11/05/2023 |
Former positions of Jonathan W. Chen
Companies | Position | End |
---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 31/12/2010 |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | 30/04/2005 |
LOMBARD MEDICAL, INC. | Director/Board Member | - |
Training of Jonathan W. Chen
Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
LOMBARD MEDICAL, INC. | Health Technology |
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
Private companies | 4 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Credit Suisse First Boston Corp. | Finance |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
- Stock Market
- Insiders
- Jonathan W. Chen